Novo Nordisk
NVO
#110
Rank
A$258.74 B
Marketcap
A$58.71
Share price
-3.12%
Change (1 day)
-19.64%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report